Reporte zur Charge EN9208

Symptomtext

Low grade fever; chills; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 38 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in arm, administration date 26Mar2021 11:00 (Lot number: EN9208) at the age of 38 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose:1st, Time:11:00, Anatomical site of injection: Shoulder, Route of administration: Intramuscular, Batch/Lot number: EM9809 EUA 12-2020), administration date: 05Mar2021, for COVID-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 26Mar2021 14:00, outcome "recovered" (28Mar2021), described as "Low grade fever"; CHILLS (non-serious) with onset 26Mar2021 14:00, outcome "recovered" (28Mar2021), described as "chills"; HEADACHE (non-serious) with onset 26Mar2021 14:00, outcome "recovered" (28Mar2021), described as "headache". Therapeutic measures were not taken as a result of pyrexia, chills, headache. No follow-up attempts are possible. No further information is expected.